| | Author (year) | No. of DAT | No. of control | Association between the risk of DAT and IDE gene polymorphism | SNP (NCBI dbs.rs.no.) |
| | Abraham et al. [20]
| 86
| 94 | No association
| 3758505, 464953,
4646954, 4646958 | | Boussaha et al. [21] | 202 | 186 | No association | 1999764, 1855916 | | Edland et al. [16];
Edland [22] | 80 | 118 | Association among DAT patients without ApoE ε4 | 3758505, 4646954, 4646958 | | Sakai et al. [23] | 240 | 163 | No association | 1999764, 551266 | | Bian et al. [17] | 210 | 200 | Association among DAT patients with ApoE ε4 | 4646953 | | Nowotny et al. [18] | 1217 | 1257 | Association among DAT patients regardless of
ApoE ε4 | 2251101 | | Cellini et al.
[24] | 302 | 164 | No association | 3758505, 4646958 | | Ozturk et al.
[25] | 1012 | 771 | No association | 2251101, 551266, 1832196 | | Marlowe et al. [26] | 179 | 516 | No association | 3758505, 4646954, 1832196, 4646958, 1544210 | | Mueller et al. [19] | 444 | 269 | Association among DAT patients | 11187007, 2149632,
7084090, 11187033, 11187033, 11187040,
11187060, 12412249, 7076966 |
|
|
